Research Toward a Cure Trials
Ending HIV requires sustained research. TAG’s April 2026 cure trials update tracks clinical studies worldwide, helping advocates, researchers, and communities follow progress toward a cure.
TAG Public Comments for the AIDS Research Advisory Council (ARAC) Meeting, April 6, 2026: Renewing Funding for the HIV Clinical Trial Networks
TAG recommends that the AIDS Research Advisory Council (ARAC) endorse NIAID's continued support of a balanced and comprehensive portfolio of basic, clinical, and implementation science — including a funding opportunity to renew its four current networks: the Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG), the International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT), the HIV Prevention Trials Network (HPTN), and the HIV Vaccine Trials Network (HVTN) or the updated IBPTN.
TAG Condemns Latest U.S. “Forever” War in the Middle East, Calls for Reprogramming Billions from Military Aggression to Health and Research
TAG condemns the United States’ war in Iran and neighboring countries. At a time when U.S. investment in public health is being slashed, the Trump administration has chosen to spend billions of dollars per day on weapons used in a war of choice for which no credible rationale has been proposed. Our government should invest in our communities by spending funds that were already appropriated and illegally impounded by the White House Office of Management and Budget to keep people healthy, rather than starting new wars that put the entire world’s health at risk.
2026 Pre-CROI Community HIV Cure Research Workshop
The 2026 Pre-CROI Community HIV Cure Research Workshop took place on Saturday, February 21, in Denver. Check out all of the recordings and slides, now linked.
TAG Condemns Illegal, Partisan CDC Cuts Proposed by White House
TAG condemns the White House’s proposed retroactive $600 million cuts to CDC programs in four states. Because Congress already appropriated these funds, the cuts are illegal and unconstitutional, threatening HIV and public health programs nationwide. Congress must reject these partisan attacks and protect public health funding.
Act Now: End AIDS and TAG Warn Against Erasure of Black HIV Awareness, Call for Action on National Black HIV/AIDS Awareness Day
This National Black HIV/AIDS Awareness Day, Act Now: End AIDS and TAG uplift the truth: Black people are disproportionately impacted by HIV, and equity-driven solutions are essential. Ending the HIV epidemic requires confronting racism, expanding access to prevention and care, and ensuring that Black communities are centered, visible, and supported in public health efforts.
This Year, Our Board Saw Firsthand What We Are Up Against
This year revealed how far this administration is willing to go in undermining public health. The White House refused to recognize World AIDS Day. Global and domestic HIV, TB, and HCV programs were directly threatened, and many were terminated. Senior CDC leaders resigned rather than carry out political firings or oversee the degradation of national vaccine guidance. And in August, a vigilante encouraged by political rhetoric fired nearly 500 rounds into the CDC campus in Atlanta and killed a police officer. The President has still not publicly acknowledged the attack.
TAGLine 2025: A Year of Action
TAGLine 2025 documents a year of action as Treatment Action Group defended science, confronted attacks on public health, and fought to protect communities impacted by HIV, TB, and HCV.
New Report Urges Action to Ensure Sustainable, Affordable Supply of Key Vaccine Adjuvants for Global Health Use
Behind many lifesaving vaccines is a fragile supply chain that few people ever see. This new TAG report examines how weaknesses in the production and supply of key vaccine adjuvants (an ingredient that enhances the immune response) can create bottlenecks that threaten global access to vaccines, underscoring the importance of greater market transparency, security, and competitiveness among governments, funders, and pharmaceutical companies.
From Forest to Factory: Tracing the Supply Chains for Two Modern Adjuvants of Global Health Importance — QS-21 and MPL
From Forest to Factory: Tracing the Supply Chains for Two Modern Adjuvants of Global Health Importance — QS-21 and MPL provides a first of its kind analysis of the global supply chains of two key adjuvants used in several of the world’s most important vaccines.